FRANCESCA VAN SANT: Open Payments
NPI 1174033500 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,297 in 110 payments from 40 companies in 2025. Trend: 2023 $4,100 · 2024 $2,493 · 2025 $5,297
Food & beverage: $2,730Consulting: $1,307Long term medical supply or device loan: $1,080Education: $180
| Company | Payments | Amount |
|---|---|---|
| Fennec Pharmaceuticals, Inc. | 7 | $1,575 |
| Novartis Pharmaceuticals Corporation | 23 | $1,381 |
| Janssen Biotech, Inc. | 12 | $433 |
| Incyte Corporation | 4 | $177 |
| Merck Sharp & Dohme LLC | 6 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $142 |
| Aveo Pharmaceuticals, Inc. | 4 | $124 |
| ABBVIE INC. | 5 | $118 |
| PFIZER INC. | 3 | $88 |
| Janssen Scientific Affairs, LLC | 1 | $83 |
Products named: Fyarro, KISQALI, Pedmark, ERLEADA, JAKAFI, KEYTRUDA, TALVEY, FOTIVDA.
Industry payments across MD — which companies pay providers there.
